Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
It seems like every week or two that an industry newsletter or publication announces that another eye-care practice has entered into a major transaction with a private equity (PE)–backed company. This transaction activity has increased substantially over the past several years.
Much has been written during my 30-plus years as an ophthalmic consultant about the various ways to structure an associate buy-in plan. But now, the current market activity involving private equity (PE) in ophthalmology practices is raising the question of how relevant the historical norms or valuation methods normally used in these transactions are. PE investors apply a more commercial, business-like approach to valuation.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
